I am a
Home I AM A Search Login

Papers of the Week


Papers: 18 May 2019 - 24 May 2019


Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 May 16


J Headache Pain


20


1

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.

Authors

van Hoogstraten W S, Maassen Van Den Brink A
J Headache Pain. 2019 May 16; 20(1):54.
PMID: 31096904.

Abstract

The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk for developing medication overuse headache (MOH). Thus, new acutely acting antimigraine drugs are currently being developed, among which the small molecule CGRP receptor antagonists, gepants, and the 5-HT receptor agonist lasmiditan. Whether treatment with these drugs carries the same risk for developing MOH is currently unknown.